Schedule 13G ownership disclosure

RIGEL PHARMACEUTICALS INC

Security class unavailable · CUSIP: 766559603

Event date: 2021-08-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,406,200
Percent of class
0.8200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-21-000392
Form type
SC 13G/A
Filer
RIGEL PHARMACEUTICALS INC
CIK
CIK 1034842
Filed
Sep 10, 2021
Reporting period
Aug 31, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub